Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Rating of “Moderate Buy” from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has received an average rating of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company.

Several research firms have issued reports on STVN. Wolfe Research started coverage on Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 price objective for the company. Bank of America raised their target price on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Finally, Morgan Stanley restated an “equal weight” rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd.

Stevanato Group Price Performance

Shares of NYSE STVN opened at €22.18 ($22.87) on Friday. Stevanato Group has a twelve month low of €16.56 ($17.07) and a twelve month high of €34.73 ($35.80). The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $6.72 billion, a price-to-earnings ratio of 47.19, a PEG ratio of 7.76 and a beta of 0.56. The firm has a 50-day moving average of €21.77 and a two-hundred day moving average of €20.50.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.12) EPS for the quarter, missing the consensus estimate of €0.13 ($0.13) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. During the same period in the previous year, the firm posted $0.16 EPS. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. As a group, analysts expect that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

Several institutional investors and hedge funds have recently bought and sold shares of STVN. TimesSquare Capital Management LLC boosted its stake in shares of Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock worth $71,657,000 after acquiring an additional 1,756,100 shares in the last quarter. Thrivent Financial for Lutherans grew its stake in Stevanato Group by 67.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after purchasing an additional 1,123,104 shares in the last quarter. Jennison Associates LLC bought a new stake in shares of Stevanato Group in the 4th quarter worth approximately $20,239,000. Pembroke Management LTD grew its holdings in shares of Stevanato Group by 143.7% in the 3rd quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock worth $21,023,000 after acquiring an additional 619,747 shares during the last quarter. Finally, New York State Common Retirement Fund acquired a new stake in Stevanato Group during the fourth quarter valued at $8,879,000.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.